| PU02.03 | Isolation of new CAP256-VRC26 lineage members reveals determinants of breadth and potency | Publication Only | Broadly neutralizing antibodies |
| PU03.01 | Generation of HIV-specific CD4 and CD8 T-cell clones for use in HIV viral inhibition assays | Publication Only | Cellular immunity |
| PU05.01 | Fostering transgender inclusion in HIV prevention research | Publication Only | Community engagement in prevention research |
| PU05.02 | Community-led HIV prevention increases HIV-related knowledge for youth in rural Malawi | Publication Only | Community engagement in prevention research |
| PU05.03 | Community engagement and volunteer recruitment experiences in a HIV vaccine preparedness study in Masaka, Uganda | Publication Only | Community engagement in prevention research |
| PU06.02 | Post-randomization differences in condomless vaginal sex among women randomized to DMPA-IM, copper IUD and levonorgestrel implant in the ECHO trial | Publication Only | Contraception, pregnancy and HIV prevention (incl. PMTCT) |
| PU07.01 | Learning from HIV prevention research: how hydroxychloroquine modifies the immune response and what could be the implications for prophylactic treatment of COVID-19 | Publication Only | COVID research: Applying lessons from HIV prevention to SARS CoV-2 |
| PU07.02 | It's not the time to be selfish: applying lessons learned from the HIV epidemic to COVID-19 | Publication Only | COVID research: Applying lessons from HIV prevention to SARS CoV-2 |
| PU07.03 | Epidemiological, clinical and immunological profile in SARS-CoV-2 co-infected HIV-positive young individuals | Publication Only | COVID research: Applying lessons from HIV prevention to SARS CoV-2 |
| PU08.01 | HIV status neutral community delivery of HIV pre-exposure prophylaxis to young men and women in rural KwaZulu-Natal: a pilot | Publication Only | Delivery technologies: novel approaches, formulation and multi-purpose |